Why is Trident Texofab falling/rising?

As of 10-Nov, Trident Texofab Ltd's stock price is currently at 319.05, reflecting a decrease of 11.2 points or 3.39%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in an overall decline of 8.37% during this period. Additionally, the stock's performance over the past week shows a significant drop of 9.91%, while it has also underperformed its sector by 2.2% today. Despite these recent declines, the stock has shown strong year-to-date growth of 89.68% and an impressive 198.32% increase over the past year, indicating a strong long-term performance. However, there is no information available regarding positive or negative factors that could further explain the recent price movement.
In the broader market context, Trident Texofab's recent performance contrasts sharply with the Sensex, which has only decreased by 0.53% over the past week. This indicates that the stock is experiencing a more significant downturn compared to the overall market. The trading activity in the sector has also declined by 2.74%, which may reflect a broader trend affecting investor sentiment. Despite a rise in investor participation, as evidenced by a 55.61% increase in delivery volume, the stock's short-term challenges suggest that it is struggling to maintain its momentum against both sector and market benchmarks.